BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22322600)

  • 1. Tannic acid down-regulates the angiotensin type 1 receptor through a MAPK-dependent mechanism.
    Yesudas R; Gumaste U; Snyder R; Thekkumkara T
    Mol Endocrinol; 2012 Mar; 26(3):458-70. PubMed ID: 22322600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13-cis-Retinoic acid specific down-regulation of angiotensin type 1 receptor in rat liver epithelial and aortic smooth muscle cells.
    Snyder R; Thekkumkara T
    J Mol Endocrinol; 2012 Apr; 48(2):99-114. PubMed ID: 22180636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells.
    Koganti S; Snyder R; Thekkumkara T
    Gend Med; 2012 Apr; 9(2):76-93. PubMed ID: 22366193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
    Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
    Li L; Pang XB; Chen BN; Gao L; Wang L; Wang SB; Wang SB; Liu DP; Du GH
    Biochem Biophys Res Commun; 2013 May; 435(1):69-75. PubMed ID: 23611777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear stress activates extracellular signal-regulated kinase 1/2 via the angiotensin II type 1 receptor.
    Ramkhelawon B; Rivas D; Lehoux S
    FASEB J; 2013 Aug; 27(8):3008-16. PubMed ID: 23585396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
    Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
    Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
    Mitra S; Wang X; Khaidakov M; Ding Z; Ayyadevera S; Hearnsberger E; Goyal T; Mehta JL
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):187-92. PubMed ID: 22561363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
    Chipitsyna G; Gong Q; Gray CF; Haroon Y; Kamer E; Arafat HA
    Endocrinology; 2007 May; 148(5):2198-208. PubMed ID: 17303665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-gamma-mediated transcription suppression of angiotensin II type 1 receptor gene.
    Sugawara A; Takeuchi K; Uruno A; Kudo M; Sato K; Ito S
    Hypertens Res; 2003 Aug; 26(8):623-8. PubMed ID: 14567501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent.
    Zhang ZH; Yu Y; Wei SG; Felder RB
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H742-51. PubMed ID: 22081704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
    Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
    J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
    Imayama I; Ichiki T; Patton D; Inanaga K; Miyazaki R; Ohtsubo H; Tian Q; Yano K; Sunagawa K
    Hypertension; 2008 Jun; 51(6):1631-6. PubMed ID: 18443233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway.
    Wei SG; Yu Y; Zhang ZH; Felder RB
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1425-33. PubMed ID: 19286949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
    Li L; Zhang ZG; Lei H; Wang C; Wu LP; Wang JY; Fu FY; Zhu WG; Wu LL
    PLoS One; 2013; 8(1):e49915. PubMed ID: 23349663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.